Skip Global navigation and goto content

It's a New Day in Public Health.

The Florida Department of Health works to protect, promote, and improve the health of all people in Florida through integrated state, county, and community efforts.

Skip MegaMenu and goto content
Megamenu requires javascript to be enabled in your browser.

Perinatal Hepatitis B

Florida Health

Disease Control

Protecting Babies

Download Perinatal Hepatitis B Resource Guide

Download Perinatal Hepatitis B Merlin Guidebook


Florida Perinatal Hepatitis B Prevention Program

Hepatitis B virus (HBV) infection is a serious health problem in the U.S. Transmission of HBV from mother to infant during the perinatal period confers the greatest risk of chronic infection or death from HBV-related chronic liver disease. Ninety to 95% of potential infections may be avoided through appropriate maternal screening and infant post-exposure prophylaxis.

Committed to Prevention
The Florida Perinatal Hepatitis B Prevention Program (PHBPP) is committed to the prevention of perinatal HBV infection by:

  • Identifying strategies to promote a sustainable and efficient program that is responsive to the public and the ever-changing healthcare environment.
  • Providing proactive and responsive case identification, case management, and follow-up for women, infants, and contacts. 
  • Routine screening of all women receiving prenatal care, for HBV infection, using the HBsAg test early in each pregnancy.
  • Supporting local County Health Departments (CHDs) and partners as they take the lead role in coordinating perinatal hepatitis B prevention activities in their respective communities. 

Our Objectives
Specific objectives of Florida's PHBPP are:

  • All pregnant women are tested for HBsAg.
  • A tracking system is used to ensure the infant receives appropriate post-exposure prophylaxis. 
  • HBsAg-positive women are contacted before delivery and educated about HBV infection.
  • Household and sexual contacts of HBsAg-positive women receive pre-vaccination testing, HBIG (if necessary), and hepatitis B vaccine at recommended intervals.
  • Infants born to HBsAg-positive mothers receive post-vaccination testing in a timely manner to ensure protection against HBV infection. 
  • Infants born to HBsAg-positive women and those of unknown status receive hepatitis B immune globulin (HBIG) and hepatitis B vaccine within 12 hours of birth, with follow-up doses of vaccine at 1 and 6 months of age.
  • Medical providers and delivery facilities are informed of the mothers HBsAg status. 

Florida's overall goal is to ensure that all HBsAg-positive pregnant women receive enhanced case management services.


Get in Contact

Under Florida law, e-mail addresses are public records. If you do not want your e-mail address released in response to a public records request, do not send electronic mail to this entity. Instead, contact this office by phone or in writing.

For further information, contact the Perinatal Hepatitis B Prevention Program Coordinator at

*Note: This page contains materials in the Portable Document Format (PDF). The free Acrobat Reader may be required to view these files.